Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2146 to 2160 of 8926 results

  1. Radiofrequency ablation of the basivertebral nerve for chronic low back pain

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Epicranial focal cortex stimulation for drug-resistant focal epilepsy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. MRI-guided laser interstitial thermal therapy for early prostate cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Percutaneous nephrolithotomy for kidney stones greater than 1.5cm

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. eXroid for internal haemorrhoids

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  7. Surgical mesh for treatment of primary ventral hernias

    In development Reference number: GID-HTE10080 Expected publication date:  03 February 2027

    Health technology evaluations
    In development

  8. Insulin efsitora alfa for treating type 2 diabetes [ID6499]

    In development Reference number: GID-TA11644 Expected publication date:  22 October 2026

    Technology appraisal guidance
    In development

  9. Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624]

    Awaiting development Reference number: GID-TA11816 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Tirzepatide for treating type 2 diabetes in people 10 to 17 years [ID6539]

    Awaiting development Reference number: GID-TA11700 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]

    In development Reference number: GID-TA11036 Expected publication date: TBC

    Technology appraisal guidance
    In development

  12. Etrolizumab for treating moderately to severely active ulcerative colitis [ID3827]

    Awaiting development Reference number: GID-TA10717 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Diverticular disease

    Awaiting development Reference number: GID-QS10086 Expected publication date: TBC

    Quality standard
    Awaiting development

  14. Thyroid disease

    Awaiting development Reference number: GID-QS10088 Expected publication date: TBC

    Quality standard
    Awaiting development

  15. Survodutide for managing overweight and obesity [ID6752]

    Awaiting development Reference number: GID-TA11986 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development